 |
 Video: What is a Stock Split?
|
|
|
| AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular ribonucleic acid (RNA) molecules, and Alferon N Injection (Interferon alfa). Its lead product is an investigational drug called Ampligen (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system. According to our AIM split history records, AIM ImmunoTech has had 1 split. | |
|
AIM ImmunoTech (AIM) has 1 split in our AIM split history database. The split for AIM took place on February 10, 2026. This was a 1031 for 1000 split, meaning for each 1000 shares of AIM owned pre-split, the shareholder now owned 1031 shares. For example, a 1000 share position pre-split, became a 1031 share position following the split.
When a company such as AIM ImmunoTech splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the AIM split history from start to finish, an original position size of 1000 shares would have turned into 1031 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AIM ImmunoTech shares, starting with a $10,000 purchase of AIM, presented on a split-history-adjusted basis factoring in the complete AIM split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/14/2016 |
|
| End date: |
06/12/2026 |
|
| Start price/share: |
$0.11 |
|
| End price/share: |
$0.41 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
272.73% |
|
| Average Annual Total Return: |
14.06% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$37,267.79 |
|
| Years: |
10.00 |
|
|
|
| Date |
Ratio |
| 02/10/2026 | 1031 for 1000 |
|
|
Free AIM Email Alerts:
